Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods

Stroke

Volumn 46, Issue 7, 2015, Pages 1800-1805

  Sajobi, Tolulope T ^a,b   Zhang, Yukun ^a,c   Menon, Bijoy K ^a,b   Goyal, Mayank ^a,b   Demchuk, Andrew M ^a,b   Broderick, Joseph P ^a,d   Hill, Michael D ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

analysis; angiography; carotid artery, internal; middle cerebral artery

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; ALBERTA STROKE PROGRAM EARLY CT SCORE; ARTICLE; ASSESSMENT OF HUMANS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; EFFECT SIZE; FEMALE; HUMAN; INGUINAL REGION; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONTE CARLO METHOD; PRIORITY JOURNAL; PUNCTURE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; REGRESSION ANALYSIS; COMPARATIVE STUDY; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; STROKE; TREATMENT OUTCOME;

BRAIN ISCHEMIA; CLINICAL TRIALS, PHASE III AS TOPIC; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MONTE CARLO METHOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84942944349     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009328     Document Type: Article

References (11)

1. Agresti A. Models for multinomial response. In: Categorical Data Analysis. Hoboken, NJ: Wiley; 2013:293-338.
2. Howard G, Waller JL, Voeks JH, Howard VJ, Jauch EC, Lees KR, et al. A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke. 2012;43:664-669. doi:10.1161/STROKEAHA.111.632935.
3. Saver JL. Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices. Stroke. 2011;42:2356-2362. doi: 10.1161/STROKEAHA.111.619122.
4. Hong KS, Saver JL. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Stroke. 2010;41:471-477. doi: 10.1161/STROKEAHA.109.571083.
5. Demchuk AM, Goyal M, Menon BK, Eesa M, Ryckborst KJ, Kamal N, et al; ESCAPE Trial Investigators. Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke. 2015;10:429-438. doi: 10.1111/ijs.12424.
6. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019-1030. doi: 10.1056/NEJMoa1414905.
7. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893-903. doi: 10.1056/NEJMoa1214300.
8. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
9. Walters SJ, Campbell MJ, Lall R. Design and analysis of trials with quality of life as an outcome: a practical guide. J Biopharm Stat. 2001;11:155-176. doi: 10.1081/BIP-100107655.
10. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009-1018. doi: 10.1056/NEJMoa1414792.
11. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke [published online ahead of print April 17, 2015]. N Engl J Med. doi: 10.1056/NEJMoa1415061. http://www.nejm.org/doi/full/10.1056/NEJMoa1415061. Accessed May 15, 2015..